Search results for "World Health Organization"

showing 10 items of 93 documents

The WHO guidelines for chronic hepatitis B fail to detect half of the patients in need of treatment in Ethiopia

2019

Background & Aims In 2015, the World Health Organization (WHO) issued guidelines for the management of chronic hepatitis B (CHB) in low- and middle-income countries, but little is known about the applicability of the WHO treatment criteria in sub-Saharan Africa. The aim of this study was to evaluate the diagnostic performance of the WHO guidelines in a large CHB cohort in Ethiopia. Methods Treatment-naive adults who attended a public CHB clinic in Addis Ababa were included in this analysis. All patients underwent a standardized evaluation at recruitment, including blood tests and transient elastography (Fibroscan®). A Fibroscan result >7.9 kPa was used to define significant fibrosis and >9.…

AdultMale0301 basic medicinemedicine.medical_specialtyCirrhosisWorld Health Organization03 medical and health sciencesHepatitis B Chronic0302 clinical medicineChronic hepatitisInternal medicinemedicineHumansHepatologybusiness.industryGold standardAntiviral therapyAlanine Transaminasemedicine.disease030104 developmental biologyWho guidelinesPractice Guidelines as TopicCohortElasticity Imaging TechniquesFemale030211 gastroenterology & hepatologyEthiopiabusinessTransient elastographyViral hepatitisJournal of Hepatology
researchProduct

The association between different domains of quality of life and symptoms in primary care patients with emotional disorders

2018

AbstractDespite the importance of quality of life (QoL) in primary care patients with emotional disorders, the specific influence of the symptoms of these disorders and the sociodemographic characteristics of patients on the various QoL domains has received scant attention. The aim of the present study of primary care patients with emotional disorders was to analyse the associations between four different QoL domains and the most prevalent clinical symptoms (i.e., depression, anxiety and somatization), while controlling for sociodemographic variables. A total of 1241 participants from 28 primary care centres in Spain were assessed with the following instruments: the Patient Health Questionn…

AdultMaleAdolescentlcsh:MedicineAnxietyWorld Health OrganizationArticleYoung Adult03 medical and health sciences0302 clinical medicineQuality of lifeSurveys and QuestionnairesHumansMedicine030212 general & internal medicineYoung adultlcsh:ScienceSomatoform DisordersDepression (differential diagnoses)AgedMultidisciplinaryPrimary Health CareDepressionbusiness.industrylcsh:REmocionsMiddle Agedmedicine.diseaseExplained variationhumanities030227 psychiatryPatient Health QuestionnairePsicologiaSpainQuality of LifeRegression AnalysisMarital statusAnxietylcsh:QFemalemedicine.symptombusinessSomatizationClinical psychologyScientific Reports
researchProduct

WHO-defined ‘myelodysplastic syndrome with isolated del(5q)’ in 88 consecutive patients: survival data, leukemic transformation rates and prevalence …

2010

The 2008 World Health Organization (WHO) criteria were used to identify 88 consecutive Mayo Clinic patients with 'myelodysplastic syndrome with isolated del(5q)' (median age 74 years; 60 females). In all, 60 (68%) patients were followed up to the time of their death. Overall median survival was 66 months; leukemic transformation was documented in five (5.7%) cases. Multivariable analysis identified age >or=70 years (P=0.01), transfusion need at diagnosis (P=0.04) and dysgranulopoiesis (P=0.02) as independent predictors of shortened survival; the presence of zero (low risk), one (intermediate risk) or >or=2 (high risk) risk factors corresponded to median survivals of 102, 52 and 27 months, r…

AdultMaleCancer Researchmedicine.medical_specialtyIDH1Biology5q-World Health OrganizationPolymerase Chain ReactionGastroenterologyIDH2ironInternal medicineMyelodysplastic Syndrome with Isolated del(5q)medicineHumansSurvival rateAgedAged 80 and overThrombopoietin receptorHematologyMyelodysplastic syndromesferritinHematologyJanus Kinase 2Middle AgedPrognosismedicine.diseaseIsocitrate DehydrogenaseSurvival RateLeukemiaCell Transformation NeoplasticOncologyMyelodysplastic SyndromesMutationImmunologyChromosomes Human Pair 5Original ArticleFemaleChromosome DeletionReceptors ThrombopoietinLeukemia
researchProduct

Reproducibility of the WHO histological criteria for the diagnosis of Philadelphia chromosome-negative myeloproliferative neoplasms

2014

This study, performed on behalf of the Italian Registry of Thrombocythaemias (Registro Italiano Trombocitemie), aimed to test the inter-observer reproducibility of the histological parameters proposed by the WHO classification for the diagnosis of the Philadelphia chromosome-negative myeloproliferative neoplasms. A series of 103 bone marrow biopsy samples of Philadelphia chromosome-negative myeloproliferative neoplasms consecutively collected in 2004 were classified according to the WHO criteria as follows: essential thrombocythaemia (n=34), primary myelofibrosis (n=44) and polycythaemia vera (n=25). Two independent groups of pathologists reviewed the bone marrow biopsies. The first group w…

AdultMalePolycythaemiaPathologymedicine.medical_specialtymyeloproliferative neoplasmPhiladelphia Chromosome Negativeessential thrombocythaemiaWorld Health Organizationpolycythaemia veramyeloproliferative neoplasmsPathology and Forensic MedicineYoung AdultCohen's kappaBone Marrowhemic and lymphatic diseasesBiopsyHumansMedicinePhiladelphia ChromosomeMyelofibrosisPolycythemia VeraAgedAged 80 and overObserver VariationWHO classificationmedicine.diagnostic_testbusiness.industryprimary myelofibrosiReproducibility of ResultsMiddle Agedmedicine.diseaseprimary myelofibrosisFemaleWho criteriaDifferential diagnosisessential thrombocythaemia; myeloproliferative neoplasms; primary myelofibrosis; polycythaemia vera; WHO classificationbusinessWho classificationThrombocythemia EssentialModern Pathology
researchProduct

Trends in mortality related to pulmonary embolism in the European Region, 2000-15: analysis of vital registration data from the WHO Mortality Database

2020

Summary Background European estimates of the burden imposed by pulmonary embolism are not available to this date. We aimed to assess pulmonary embolism-related mortality and time trends in the WHO European Region. Methods We analysed vital registration data from the WHO Mortality Database (2000–15) covering subregions of the WHO European Region: Eastern Europe, Northern Europe, Southern Europe, Western Europe, and Central Asia. Deaths were considered pulmonary embolism-related if International Classification of Disease-10 code for acute pulmonary embolism (I26) or any code for deep or superficial vein thrombosis was listed as the primary cause of death. We used locally estimated scatterplot…

AdultMalePulmonary and Respiratory MedicineAdolescentDatabases FactualSuperficial vein thrombosisPopulation610 Medicine & healthWorld Health Organizationcomputer.software_genreYoung AdultCase fatality rateHumansMedicineeducationAgedCause of deathAged 80 and overeducation.field_of_studyDatabasebusiness.industryIncidenceIncidence (epidemiology)Mortality rate10031 Clinic for AngiologyMiddle Agedmedicine.diseasePulmonary embolismEurope2740 Pulmonary and Respiratory MedicineAsia CentralFemalePulmonary EmbolismbusinesscomputerCohort study
researchProduct

Pooled analysis of who surgical safety checklist use and mortality after emergency laparotomy

2019

Background The World Health Organization (WHO) Surgical Safety Checklist has fostered safe practice for 10 years, yet its place in emergency surgery has not been assessed on a global scale. The aim of this study was to evaluate reported checklist use in emergency settings and examine the relationship with perioperative mortality in patients who had emergency laparotomy. Methods In two multinational cohort studies, adults undergoing emergency laparotomy were compared with those having elective gastrointestinal surgery. Relationships between reported checklist use and mortality were determined using multivariable logistic regression and bootstrapped simulation. Results Of 12 296 patients incl…

AdultMalebarriershumanoschecklist; surgery; human development indexGlobalSurg CollaborativeWHO Surgical Safety Checklist mortality emergency laparotomyWorld Health Organizationseguridad del pacienteNOCohort Studieslista de controlestudios prospectivosHumanstasa de supervivenciaProspective Studiesimplementationestudios de cohortesSurgery; implementation; health; barriersEmergency Treatment11 Medical and Health Sciencesmediana edadDigestive System Surgical ProceduresAgedancianoLaparotomyScience & TechnologyhealthOriginal ArticlesadultoMiddle Agedchecklist WHOprocedimientos quirúrgicos del sistema digestivoChecklistSurvival RateElective Surgical Procedureslaparotomíatratamiento de urgenciaSurgeryOriginal ArticleFemalePatient SafetyLife Sciences & Biomedicine
researchProduct

Utility of the World Health Organization Disability Assessment Schedule II in schizophrenia.

2011

The World Health Organization Disability Assessment Schedule II (WHODAS II) was developed for assessing disability. This study provides data on the validity and utility of the Spanish version of the WHODAS II in a large sample of patients with schizophrenia.The sample included 352 patients with a schizophrenia spectrum disorder. They completed a comprehensive assessment battery including measures of psychopathology, functionality and quality-of-life. A sub-sample of 36 patients was retested after six months to assess its temporal stability.Participation in society (6.3%) and Life activities (4.0%) were the domains with the highest percentage of missing data. The internal consistency (Cronba…

AdultMalemedicine.medical_specialtyActivities of daily livingAdolescentPsychometricsIntraclass correlationWorld Health OrganizationSeverity of Illness IndexQuality of life (healthcare)Cronbach's alphaActivities of Daily LivingmedicineHumansDisabled PersonsPsychiatryBiological PsychiatryReproducibility of ResultsMiddle AgedMissing datamedicine.diseasePsychiatry and Mental healthPsychotic DisordersSchizophreniaScale (social sciences)Quality of LifeSchizophreniaFemalePsychologyClinical psychologyPsychopathologySchizophrenia research
researchProduct

Disability in bipolar I disorder: the 36-item World Health Organization Disability Assessment Schedule 2.0.

2014

Abstract Background The WHODAS 2.0 is an ICF-based multidimensional instrument developed for measuring disability. The present study analyzes the utility of the 36-item interviewer-administered version in a sample of patients with bipolar disorder. There is no study to date that analyses how the scale works in a sample that only comprises such patients. Methods A total of 291 patients with bipolar disorder (42.6% males) according to DSM-IV-TR criteria from a cross-sectional study conducted in outpatient psychiatric clinics were enrolled. In addition to the WHODAS 2.0, patients completed a comprehensive assessment battery including measures on psychopathology, functionality and quality of li…

AdultMalemedicine.medical_specialtyBipolar I disorderActivities of daily livingBipolar DisorderPsychometricsPsychological interventionWorld Health OrganizationDisability EvaluationQuality of life (healthcare)Cronbach's alphaActivities of Daily LivingmedicineHumansDisabled PersonsBipolar disorderPsychiatryReproducibility of ResultsMiddle Agedmedicine.diseaseSelf CarePsychiatry and Mental healthClinical PsychologyMoodCross-Sectional StudiesQuality of LifeFemalePsychologyPsychopathologyClinical psychologyJournal of affective disorders
researchProduct

Impact of the WHO depression guideline on patient care by psychiatrists: a randomized controlled trial.

2008

AbstractBackgroundScientific literature reviews aim to summarize the state of knowledge and published empirical evidence. In contrast, medical guidelines are intervention tools that aim to improve physician behaviour and patient outcome. They can have positive effects, but they can also have negative effects. Their effects must be tested by research.MethodsIn a randomized controlled trial, 103 psychiatrists in private practice were either provided with the WHO depression guideline only (information group), or provided with the WHO depression guideline and trained for one day in this guideline (intervention group), or left uninformed (control group). They then treated a total of 497 patients…

AdultMalemedicine.medical_specialtyEvidence-based practiceInservice TrainingMirtazapineMianserinAntidepressive Agents TricyclicWorld Health Organizationlaw.invention03 medical and health sciences0302 clinical medicineContinuing medical educationRandomized controlled triallawGermanymedicineHumans030212 general & internal medicinePsychiatryAgedPsychiatryDepressive Disorderbusiness.industryEvidence-based medicineGuidelineMiddle AgedMental health030227 psychiatryPsychiatry and Mental healthAffectPrivate practicePractice Guidelines as TopicPhysical therapyFemalebusinessPsychosocialEuropean psychiatry : the journal of the Association of European Psychiatrists
researchProduct

An observational retrospective study of odontogenic cyst´s and tumours over an 18-year period in a Portuguese population according to the new WHO Hea…

2020

Background Odontogenic cysts and tumours of the jaws represent one of the most prevalent groups of oral-maxillofacial lesions. We aimed to evaluate the clinical and pathological characteristics of a cohort of odontogenic cysts (OC) and odontogenic tumours (OT) of the jaws in a Portuguese population. Material and Methods This observational retrospective study analysed patients diagnosed with either an OC or OT of the jaws at a central hospital of Oporto, Portugal, between 1988 and 2006. Data collected from patients’ files included demographic, clinical, radiological and histopathological information. Recurrence was evaluated using univariate and multivariate analysis. Results The sample cons…

AdultMalemedicine.medical_specialtyMultivariate analysisWorld Health OrganizationLesionYoung Adultpd-l1Odontogenic cystHumansMedicineGeneral DentistryPathologicalUNESCO:CIENCIAS MÉDICASRetrospective StudiesRadicular CystOral Medicine and PathologyPortugalbusiness.industryResearchRetrospective cohort studyMiddle Agedoral cancermedicine.diseaseDermatologystomatognathic diseasespd1OtorhinolaryngologyHead and Neck NeoplasmsOdontogenic CystsCohortFemaleSurgeryObservational studyimmunotherapyNeoplasm Recurrence Localmedicine.symptombusinessoral mucositisMedicina Oral Patología Oral y Cirugia Bucal
researchProduct